Can large national health plans make an impact in reducing prescribing of high-risk medications to people with Alzheimer’s disease or related dementias by mailing patients, caregivers and their health care providers educational materials?
Can large national health plans make an impact in reducing prescribing of high-risk medications to people with Alzheimer’s disease or related dementias by mailing patients, caregivers and their health care providers educational materials?